Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
remacemide
Description:
A drug compound investigated for anticonvulsant effects and as an adjunct treatment for Parkinson’s disease.
Primary topic:
Epilepsy research and treatment (37%)
Related topics:
Epilepsy research and treatment (37%),
Neuroscience and Neuropharmacology Research (14%),
Genetic Neurodegenerative Diseases (9%),
Parkinson's Disease Mechanisms and Treatments (8%)
Wikidata ID:
wiki/Q7311505
OpenAlex ID:
keywords/remacemide
Therapeutic Effects of Coenzyme Q10and Remacemide in Transgenic Mouse Models of Huntington's Disease
2002
·
Robert J. Ferrante
, Ole A. Andreassen
, et al.
·
Journal of Neuroscience
·
426
PDF
A randomized, placebo-controlled trial of coenzyme Q 10 and remacemide in Huntington’s disease
2001
·
The Huntington Study Group
·
Neurology
·
398
Update on the Mechanism of Action of Antiepileptic Drugs
1996
·
Brian S. Meldrum
·
Epilepsia
·
274
Ontogeny of the N-Methyl-D-Aspartate (NMDA) Receptor System and Susceptibility to Neurotoxicity
2002
·
K. A. Haberny
, Merle G Paule
, et al.
·
Toxicological Sciences
·
245
Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions
2009
·
Jarogniew J. Łuszczki
·
Pharmacological Reports
·
225
Progress report on new antiepileptic drugs: a summary of the fourth Eilat conference (EILAT IV)
1999
·
M Bialer
, S.I Johannessen
, et al.
·
Epilepsy Research
·
196
The Clinical Pharmacokinetics of the Newer Antiepileptic Drugs: Focus on Topiramate, Zonisamide and Tiagabine
1996
·
Emilio Perucca
, Meir Bialer
·
Clinical Pharmacokinetics
·
183
Coenzyme Q 10 as a Possible Treatment for Neurodegenerative Diseases
2002
·
M. Flint Beal
·
Free Radical Research
·
169
Neuroprotection of the Brain During Cardiopulmonary Bypass: A Randomized Trial of Remacemide During Coronary Artery Bypass in 171 Patients
1998
·
J.E. Arrowsmith
, M.J.G. Harrison
, et al.
·
Stroke
·
164
Neuroprotection by NMDA Receptor Antagonists in a Variety of Neuropathologies
2001
·
Gene Palmer
·
Current Drug Targets
·
161
Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease
1994
·
J. Timothy Greenamyre
, Robert V. Eller
, et al.
·
Annals of Neurology
·
160
Exitatory Amino Acids in Health and Disease
1995
·
Robert Joseph Thomas
·
Journal of the American Geriatrics Society
·
147
Regional Variations in the Pharmacology of NMDA Receptor Channel Blockers: Implications for Therapeutic Potential
1995
·
Richard H. P. Porter
, J. Timothy Greenamyre
·
Journal of Neurochemistry
·
147
Pharmacological perioperative brain neuroprotection: a qualitative review of randomized clinical trials
2013
·
F. Bilotta
, A.W. Gelb
, et al.
·
British Journal of Anaesthesia
·
145
PDF
Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy
2003
·
Patrick Kwan
, Martin J. Brodie
·
Neurology
·
138
Clinical pharmacokinetics of new antiepileptic drugs
1995
·
M.C. Walker
, P.N. Patsalos
·
Pharmacology & Therapeutics
·
123
Therapeutic interventions for disease progression in Huntington's disease
2009
·
Tiago Mestre
, Joaquim Ferreira
, et al.
·
Cochrane Database of Systematic Reviews
·
117
A controlled trial of remacemide hydrochloride in Huntington's disease
1996
·
Karl Kieburtz
, Andrew Feigin
, et al.
·
Movement Disorders
·
113
Comparative Pharmacokinetics of the Newer Antiepileptic Drugs
1993
·
Meir Bialer
·
Clinical Pharmacokinetics
·
107
Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review
2001
·
A.G Marson
, J.L Hutton
, et al.
·
Epilepsy Research
·
103
The NMDA Receptor Complex: A Promising Target for Novel Antiepileptic Strategies
2001
·
B. Kohl
, G. Dannhardt
·
Current Medicinal Chemistry
·
95
Environmental, pharmacological, and genetic modulation of the HD phenotype in transgenic mice
2004
·
Gabriele Schilling
, Alena V. Savonenko
, et al.
·
Experimental Neurology
·
92
Evaluation of Dyskinesias in a Pilot, Randomized, Placebo-Controlled Trial of Remacemide in Advanced Parkinson Disease
2001
·
Parkinson Study Group
·
Archives of Neurology
·
92
Newer Antiepileptic Drugs: Towards an Improved Risk-Benefit Ratio
1994
·
Philip N. Patsalos
, Josemir W.A.S. Sander
·
Drug Safety
·
84
Biological profile of the metabolites and potential metabolites of the anticonvulsant remacemide
1992
·
Gene C. Palmer
, Robert J. Murray
, et al.
·
Epilepsy Research
·
84
Show more works
View as search
Works count:
129
Citation count:
5,815
Year
Topic
Type